Get started
STRIDES PHARMA SCIENCE LIMITEDSTRIDES PHARMA SCIENCE LIMITEDSTRIDES PHARMA SCIENCE LIMITED

STRIDES PHARMA SCIENCE LIMITED

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Forecast Seasonals

STAR chart


Full chart

STAR upcoming earnings


Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪60.29 B‬ INR
Dividend yield (indicated)
0.38%
Price to earnings Ratio (TTM)
23.25
Basic EPS (TTM)
29.30 INR
Net income (FY)
‪−1.25 B‬ INR
Revenue (FY)
‪40.20 B‬ INR
Shares float
‪61.07 M‬
Beta (1Y)
1.54

Employees


Employees (FY)
‪5.21 K‬
Change (1Y)
+589 +12.75%
Revenue / Employee (1Y)
‪7.72 M‬ INR
Net income / Employee (1Y)
‪−239.70 K‬ INR

About STRIDES PHARMA SCI LTD


Sector
Health Technology
Industry
Pharmaceuticals: Major
CEO
Badree Komandur
Website
strides.com
Headquarters
Bangalore
Founded
1990
ISIN
INE939A01011
FIGI
BBG000DQV1P3
Strides Pharma Science Ltd. engages in the development, manufacture and distribution of Internet Protocol-led generics and bio-pharmaceutical products. It operates through the Pharmaceutical and Bio-pharmaceutical business segments. The company was founded by Arun N. Kumar on June 28, 1990 and is headquartered in Bangalore, India.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

STAR news



Ideas



See all ideas 

Technicals


Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Check out other big names from the same industry as STAR.

Frequently Asked Questions


The current price of STAR is 663.20 INR — it has decreased by −3.94% in the past 24 hours. Watch STRIDES PHARMA SCIENCE LIMITED stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on BSE exchange STRIDES PHARMA SCIENCE LIMITED stocks are traded under the ticker STAR.
STAR stock has risen by 0.36% compared to the previous week, the month change is a −5.70% fall, over the last year STRIDES PHARMA SCIENCE LIMITED has showed a 56.98% increase.
We've gathered analysts' opinions on STRIDES PHARMA SCIENCE LIMITED future price: according to them, STAR price has a max estimate of 1,070.00 INR and a min estimate of 1,070.00 INR. Watch STAR chart and read a more detailed STRIDES PHARMA SCIENCE LIMITED stock forecast: see what analysts think of STRIDES PHARMA SCIENCE LIMITED and suggest that you do with its stocks.
STAR reached its all-time high on Oct 17, 2024 with the price of 804.10 INR, and its all-time low was 126.45 INR and was reached on May 11, 2022. View more price dynamics on STAR chart.
See other stocks reaching their highest and lowest prices.
STAR stock is 5.24% volatile and has beta coefficient of 1.54. Track STRIDES PHARMA SCIENCE LIMITED stock price on the chart and check out the list of the most volatile stocks — is STRIDES PHARMA SCIENCE LIMITED there?
Today STRIDES PHARMA SCIENCE LIMITED has the market capitalization of ‪60.29 B‬, it has increased by 6.12% over the last week.
Yes, you can track STRIDES PHARMA SCIENCE LIMITED financials in yearly and quarterly reports right on TradingView.
STRIDES PHARMA SCIENCE LIMITED is going to release the next earnings report on May 22, 2025. Keep track of upcoming events with our Earnings Calendar.
STRIDES PHARMA SCIENCE LIMITED revenue for the last quarter amounts to ‪11.54 B‬ INR, despite the estimated figure of ‪11.23 B‬ INR. In the next quarter, revenue is expected to reach ‪11.80 B‬ INR.
STAR net income for the last quarter is ‪879.46 M‬ INR, while the quarter before that showed ‪932.32 M‬ INR of net income which accounts for −5.67% change. Track more STRIDES PHARMA SCIENCE LIMITED financial stats to get the full picture.
Yes, STAR dividends are paid annually. The last dividend per share was 2.50 INR. As of today, Dividend Yield (TTM)% is 0.38%. Tracking STRIDES PHARMA SCIENCE LIMITED dividends might help you take more informed decisions.
As of Apr 28, 2025, the company has ‪5.21 K‬ employees. See our rating of the largest employees — is STRIDES PHARMA SCIENCE LIMITED on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. STRIDES PHARMA SCIENCE LIMITED EBITDA is ‪8.93 B‬ INR, and current EBITDA margin is 17.58%. See more stats in STRIDES PHARMA SCIENCE LIMITED financial statements.
Like other stocks, STAR shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade STRIDES PHARMA SCIENCE LIMITED stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So STRIDES PHARMA SCIENCE LIMITED technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating STRIDES PHARMA SCIENCE LIMITED stock shows the buy signal. See more of STRIDES PHARMA SCIENCE LIMITED technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.